Hilltop Holdings Inc. Nu Cana PLC Transaction History

Hilltop Holdings Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$2.7 - $5.04 $103,410 - $193,032	-38,300 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.38 - $7.0 $167,754 - $268,100	38,300 New	38,300 $191,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $64.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

Stay updated on Hilltop Holdings Inc. with notifications on news.